drugset / Trial / NCT03541889
REVEAL Biomarkers of Engraftment After Alternative Donor HSCT
Phase 1
Recruiting
56 enrolled
University of Oklahoma
Emory University · collabNational Heart, Lung, and Blood Institute (NHLBI) · collabUniversity Hospitals Cleveland Medical Center · collabUniversity of Michigan · collab
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
The purpose of this study is to find new tests that could help determine if the newly infused bone marrow cells are growing well after bone marrow transplantation or if new bone marrow cells are needed. The Investigator will use FLT imaging, an investigational imaging test, and collect blood samples to investigate whether the cells are growing well.
Timeline
- Start
- 2021-02-05
- Primary completion
- 2026-11
- Completion
- 2027-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FLT | Unknown | — | — |
Indications
No indication recorded.